Skip to main content
Fig. 3 | European Journal of Medical Research

Fig. 3

From: Schisandrin A regulates the Nrf2 signaling pathway and inhibits NLRP3 inflammasome activation to interfere with pyroptosis in a mouse model of COPD

Fig. 3

Schisandrin A (SchA) and dexamethasone (Dex) reduce emphysema, inflammatory cell infiltration and small airway remodeling in CS-induced COPD model mice. Lung tissues were stained with H&E. Representative histopathological sections of mouse lungs show A expandable alveolar spaces of different degrees (scale bar 200 μm), B invasive inflammatory cells (scale bar 100 μm), and C thickened bronchial wall (scale bar 50 μm). Different indicators were used to quantify these injuries for statistical analysis, as shown in figure (D), the mean linear intercept, which is a quantitative analysis of the severity of emphysema. In addition, quantitative analysis of pulmonary inflammation was determined by E pathological score and F measurement of the total wall area (Wat/Pbm). n = 6 mice per group. Data are shown as the mean ± SEM (F) and median ± IQR (D–E). To test for group differences, Games–Howell (F) and Kruskal‒Wallis (D–E) tests were used. *p < 0.05, **p < 0.01, ***p < 0.001 versus control group, #p < 0.05, ##p < 0.01, ###p < 0.001 versus CS group, +p < 0.05, ++p < 0.01, +++p < 0.001 versus CS + DEX group, §p < 0.05, §§p < 0.01, §§§p < 0.001 versus CS + SchA group

Back to article page